Skip to main content
SpringerLink
Log in

Pathological Assessment of Ovarian Cancer

  • Protocol
Ovarian Cancer

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 39))

  • 952 Accesses

Abstract

Ovarian neoplasms are notoriously heterogeneous-the World Health Organization classification (1) includes 46 different epithelial tumor types, 24 sex cord stromal types, 29 germ cell types, and 13 other categories, not including 17 other tumor-like conditions (Table 1). Many of these lesions are very rare, but there is tremendous variation in the biological behavior of different tumor types, and it is very important that histopathological assessment is performed accurately. This is not only crucial to the patient, whose treatment depends on it, but also in investigative work on ovarian cancer. Uniform terminology must be used to allow comparisons between different studies and any research that involves analysis of the biological or clinical features of ovarian tumors must include expert histopathological review of cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Scully, R. E., Fox, H., Russell, P., et al. International Histological Classification of Ovaria Tumors. Springer Verlag, Berlin, Germany (in press).

    Google Scholar 

  2. Yancik, R. (1993) Ovarian cancer:age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71, 517–523.

    Article  CAS  PubMed  Google Scholar 

  3. Auersperg, N., Maines-Bandiera, S. L., and Kruk, P. A. (1995) Human ovarian surface epithelium: growth patterns and differentiation, in Ovarian Cancer 3, (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 157–170.

    Google Scholar 

  4. Salazar, H., Godwin, A. K., Getts, L. A., Testa, J. R., Daly, M., Rosenblum, N., et al. Spontaneous transformation of the ovarian surface epithelium and the biology of ovarian cancer, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 145–156.

    Google Scholar 

  5. Auersperg, N., Maines-Bandiera, S. L., Dyck, H. G., and Kruk, P. A. (1994) Characterisation of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab. Invest. 71, 510–518.

    CAS  PubMed  Google Scholar 

  6. Tsao, S. W., Mok, S. C., Fey, E. G., Fletcher, J. A., Wan, T. S., Chew, E. C., et al. Characterisation of human ovarian surface epithelial cells immortalised by human papilloma virus oncogenes (HPV-E6E7 ORFs). Exp. Cell Res. 218, 499–507.

    Google Scholar 

  7. Kruk, P. A., Uitto, V. J., Firth, J. D., Dedhar, S., and Auersperg, N. (1994) Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215, 97–108.

    Article  CAS  PubMed  Google Scholar 

  8. Kruk, P. A. and Auersperg, N. (1992) Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. Amer. J. Obstet. Gynecol. 167, 1437–1443.

    CAS  Google Scholar 

  9. Berchuck, A., Rodriguez, G. C., Kamel, A., Dodge, R. K., Soper, J. T., Clarke-Pearson, D. L., and Bast, R. C. (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Amer. J Obstet. Gynecol. 164, 669–674.

    CAS  Google Scholar 

  10. Wang, D. P., Konishi, I., Koshiyama, M., Nanbu, Y., Iwai, T., Nonogaki, H., et al. (1992) Immuno-histochemical localisation of c-erb-B2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumors of the ovary. Virchows Archiv. A 421, 393–400.

    Article  CAS  Google Scholar 

  11. Berchuck, A., Rodriguez, G., Olt, G., Whitaker, R., Boente, M. P., Arrick, B. A., et al. (1992) Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor beta. Amer. J. Obstet. Gynecol. 166, 676–684.

    CAS  Google Scholar 

  12. Havrilesky, L. J., Hurteau, J. A., Whitaker, R. S., Elbendary, A., Wu, S., Rodriguez, G. C., et al. (1995) Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res. 55, 944–948.

    CAS  PubMed  Google Scholar 

  13. Jindal, S. K., Snoey, D. M., Lobb, D. K., and Dorrington, J. H. (1994) Transforming growth factor alpha localisation and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol. 53, 17–23.

    Article  CAS  PubMed  Google Scholar 

  14. Boente, M. P., Berchuck, A., Rodriguez, G. C., Davidoff, A., Whitaker, R., Xu, F. J., et al. (1992) The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells. Amer. J. Obstet. Gynecol. 167, 1877–1882.

    CAS  Google Scholar 

  15. Lidor, Y. J., Xu, F. J., Martinez-Maza, O., Olt, G. J., Marks, J. R., Berchuck, A., et al. (1993) Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp. Cell Res. 207, 332–339.

    Article  CAS  PubMed  Google Scholar 

  16. Pejovic, T. (1995) Genetic changes in ovarian cancer. Ann. Med. 27, 73–78.

    Article  CAS  PubMed  Google Scholar 

  17. Muto, M. G., Welch, W. R., Mok, S. C., Bandera, C. A., Fishbaugh, P. M., Tsao, S. W., et al. (1995). Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 55, 490–492.

    CAS  PubMed  Google Scholar 

  18. Buller, R. E. Skilling, J. S., Sood, A. K., Plaxe, S., Baergen, R. N., and Lager, D. J. (1998) Field cancer-ization: why late “recurrent” ovarian cancer is not recurrent. Amer. J. Obstet. Gynecol. 178, 641–649.

    Article  CAS  Google Scholar 

  19. Provencher, D. M., Lounis, H., Fink, D., Drouin, P., and Mes-Masson, A. M. (1997) Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer. Tumor Biol. 18, 167–174.

    Article  CAS  Google Scholar 

  20. Brescia, R. J., Barakat, R. A., Beller, U., Frederickson, G., Suhrland, M. J., et al. (1990) The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary. Cancer 65, 141–147.

    Article  CAS  PubMed  Google Scholar 

  21. Friedlander, M. L., Hedley, D. H., Taylor, I., Russell, P., and Tattersall, M. H. N. (1984) Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 44, 397–400.

    CAS  PubMed  Google Scholar 

  22. Kaern, J., Trope, C. G., Abeler, V., and Petterson, E. O. (1995) Cellular DNA content: the most important prognostic factor in patients with borderline tumors of the ovary. Can it prevent overtreatment? in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K., pp. 181–188.

    Google Scholar 

  23. Foulkes, W. D. and Trowsdale, J. (1995) Isolating tumor suppressor genes relevant to ovarian carcinoma-the role of loss of heterozygosity, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K., pp. 23–38.

    Google Scholar 

  24. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. (1991) Allelotype of human ovarian cancer. Cancer Res. 51, 5118–5122.

    CAS  PubMed  Google Scholar 

  25. Yang-Feng, T. L., Han, H., Chen, K-C., Li, S., Claus, E., Carcangui, M. L., et al. (1993) Allelic loss in ovarian cancer. Int. J. Cancer 54, 546–551.

    Article  CAS  PubMed  Google Scholar 

  26. Steel, C. M., Cohen, B. B., Lessels, A., Williams, A. R. W., and Gabra, H. (1997). Other gene aberrations in ovarian cancer, in Ovarian Cancer 4, (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K.

    Google Scholar 

  27. Obata, K., Morland, S. J. Watson, R. H., Hitchcock, A., Chenevix-Trench, G., Thomas, E. J., et al. (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095–2097.

    CAS  PubMed  Google Scholar 

  28. Skilling, J. S., Sood, A., Niemann, T., Lager, D. J., and Buller, R. E. (1996) An abundance of p53 null mutations in ovarian carcinoma. Oncogene 13, 117–123.

    CAS  PubMed  Google Scholar 

  29. Kounelis, S., Jones, M. W., Papadaki, H., Bakker, A., Swalsky, P., and Finkelstein, S. D. (1998) Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Human Pathol. 29, 82–87.

    Article  CAS  Google Scholar 

  30. Abeln, E. C., Smit, V. T., Wessels, J. W., de Leeuw, W. J., Cornelisse, C. J., and Fleuren, G. J. (1997) Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumors. J. Pathol. 183, 424–431.

    Article  CAS  PubMed  Google Scholar 

  31. Skomedal, H., Kristensen, G. B., Abeler, V. M., Borresen-Dale, A. L., Trope, C., and Holm, R. (1997) TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumors and stage I carcinomas. J. Pathol. 181, 158–165.

    Article  CAS  PubMed  Google Scholar 

  32. Zheng, J., Benedict, W. F., Xu, S. X., Kim, T. M., Velicescu, M., Wan, M., et al. (1995) Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J. Nat. Cancer Inst. 87, 1146–1153.

    Article  CAS  PubMed  Google Scholar 

  33. Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W. H., et al. (1997) WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Amer. J. Pathol. 150, 167–175.

    CAS  Google Scholar 

  34. Werness, B. A., Jobe, J. S., DiCioccio, R. A., and Piver, M. S. (1997) Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohis-tochemistry. Int. J. Gynecol. Pathol. 16, 149–155.

    Article  CAS  PubMed  Google Scholar 

  35. Milner, B. J., Hosking, L., Sun, S., Haites, N. E., and Foulkes, W. D. (1996) Polymorphisms in p21CIP1/WAF1 are not correlated with Tp53 status in sporadic ovarian tumors. Eur. J. Cancer 32A, 2360–2363.

    Article  CAS  PubMed  Google Scholar 

  36. Shih, Y. C., Kerr, J., Hurst, T. G., Khoo, S. K., Ward, B. G., and Chevenix-Trench, G. (1998) No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. Gynecol. Oncol. 69, 210–213.

    Article  CAS  PubMed  Google Scholar 

  37. Holt, J. T. (1997) Breast cancer genes: therapeutic strategies. Ann. New York Acad. Sci. 833, 34–41.

    Article  CAS  Google Scholar 

  38. Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., et al. (1996) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. New England J. Med. 335, 1413–1416.

    Article  CAS  Google Scholar 

  39. Tangir, J., Muto, M. G., Berkowitz, R. S., Welch, W. R., Bell, D. A., and Mok, S. C. (1996) A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene 12, 735–740.

    CAS  PubMed  Google Scholar 

  40. Scully, R. E., Bell, D. A., and Abu-Jawdeh, G. M. (1995) Update on early ovarian cancer and cancer developing in benign ovarian tumors, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 139–144.

    Google Scholar 

  41. Bell, D. A. and Scully, R. E. (1994) Early de novo ovarian carcinoma: a study of 14 cases. Cancer 73, 1859–1864.

    Article  CAS  PubMed  Google Scholar 

  42. Park, T. W., Felix, J. C., and Wright, T. C. (1995) X chromosome inactivation and micros atellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 55, 4793–4796.

    CAS  PubMed  Google Scholar 

  43. Hutson, R., Ramsdale, J., and Wells, M. (1995) P53 protein expression in putative precursor lesions of epithelial ovarian cancer. Histopathol. 27, 367–371.

    Article  CAS  Google Scholar 

  44. La Grenade, A. and Silverberg, S. G. (1988) Ovarian tumors associated with atypical endometriosis. Human Pathol. 19, 1080–1084.

    Article  Google Scholar 

  45. Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, A. F., Nikrui, N., and Goff, B. A. (1996) Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol. Oncol. 60, 238–244.

    Article  CAS  PubMed  Google Scholar 

  46. Mostoufizadeh, M. and Scully, R. E. (1980) Malignant tumors arising in endometriosis. Clin. Obstet. Gynecol. 23, 951–963.

    Article  CAS  PubMed  Google Scholar 

  47. Gucer, F., Pieber, D., and Arikan, M. G. (1998) Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur. J. Gynecol. Oncol. 19, 39–41.

    CAS  Google Scholar 

  48. Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., and Campbell, I. G. (1998) Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res. 58, 1707–1712.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Edinbrugh University, Edinburgh, Scotland

    Alistair R. W. Williams

Authors
  1. Alistair R. W. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Glasgow, Glasgow, Scotland

    John M. S. Bartlett

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Williams, A.R.W. (2000). Pathological Assessment of Ovarian Cancer. In: Bartlett, J.M.S. (eds) Ovarian Cancer. Methods in Molecular Medicine™, vol 39. Humana Press. https://doi.org/10.1385/1-59259-071-3:49

Download citation

  • DOI: https://doi.org/10.1385/1-59259-071-3:49

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-583-6

  • Online ISBN: 978-1-59259-071-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation